HUM logo

Humana (HUM)

Profile

Full Name

Humana Inc.

Ticker Symbol

HUM

Exchange

NYSE

Sector

Healthcare

Industry

Healthcare Plans

Country

United States

IPO

December 31, 1981

Indexes

S&P 500

Website

http://www.humana.com

Employees

65680

Key Details

Price

$284.82(-3.46%)

Market cap

Last Dividend

$0.89

TTM Dividend yield

1.24%

Annual revenue

$117.76B(+10.70% YoY)

Annual EPS

$9.98(-50.10% YoY)

PE ratio

28.63

Next earnings date

Apr 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$284.82
HUM price is $284.82

30-Day Relative Volume

0.93
HUM 30-day relative volume is 0.93

Price Performance

Price Most recent change

-3.46%
HUM price was down -3.46% on Apr 14, 2025

Price YTD change

+12.26%
HUM price is up +12.26% since January 1st

Price 1-year change

-8.88%
HUM price is down -8.88% year-on-year

Price 3-year change

-38.16%
HUM price is down -38.16% over the past 3 years

Price Range

Price All-time high

$571.30
HUM price is currently -50.15% below its historical high of $571.30

Price 3-year low

$213.31
HUM price is currently +33.52% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$34.36B
HUM market capitalization is $34.36 billion

Market cap 3-year change

-41.02%
HUM market capitalization is down -41.02% over the past 3 years

Market cap All-time high

$71.28B
HUM market capitalization is currently -51.79% below its historical high of $71.28 billion

Market cap sector rank

97.04%
HUM market capitalization is higher than 97.04% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.12%
HUM shares outstanding is up +0.12% year-on-year

Shares Outstanding 3-Year Change

-4.62%
HUM shares outstanding is down -4.62% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.26
HUM beta is 0.26

200-day SMA

$298.26
HUM price is currently -4.51% below its 200-day simple moving average

50-day SMA

$266.68
HUM price is currently +6.80% above its 50-day simple moving average

RSI

59.67
HUM 14-day relative strength index is 59.67

Volume

0.93
HUM 30-day relative volume is 0.93

ATR

$13.05
HUM average true range is $13.05

10-day Historical Volatility

64.11%
HUM 10-day historical volatility is 64.11%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.89
HUM last dividend was $0.89 per share, with an ex-dividend date of March 28, 2025

Next Dividend

-
HUM next dividend has not yet been announced

Dividend per share

Dividend per share

$3.54
HUM annual dividend per share is $3.54

Dividend per share Sector Rank

87.21%
HUM annual dividend per share is higher than 87.21% of companies in Healthcare sector

Dividend per share 1-Year Change

0%
HUM {parameterFullLabel} has remained unchanged year-on-year

Dividend per share 3-Year Change

+26.43%
HUM annual dividend per share is up +26.43% over the past 3 years

Dividend yield

Dividend yield

1.24%
HUM annual dividend yield is 1.24%

Dividend yield Sector Rank

34.12%
HUM annual dividend yield is higher than 34.12% of companies in Healthcare sector

Other

Payout ratio

35.71%
HUM annual payout ratio is 35.71%

Dividends paid

$431.00M
HUM annual dividends paid is $431.00 million

Free cash flow

$2.39B
HUM annual free cash flow is $2.39 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$117.76B
HUM annual revenue is $117.76 billion

Revenue Analysts estimate

$125.15B
HUM annual revenue is currently -5.91% lower than the consensus analysts' forecast

Revenue 1-year change

+10.7%
HUM annual revenue is up +10.7% year-on-year

Revenue Sector rank

98.99%
HUM annual revenue is higher than 98.99% of companies in Healthcare sector

EPS

EPS

$9.98
HUM annual earnings per share is $9.98

EPS Analysts estimate

$16.38
HUM annual earnings per share is currently -39.08% lower than the consensus analysts' forecast

EPS 1-year change

-50.1%
HUM annual earnings per share is down -50.1% year-on-year

EPS Sector rank

98.1%
HUM annual earnings per share is higher than 98.1% of companies in Healthcare sector

Profit

Gross profit

-
HUM annual gross profit value is unknown

Gross margin

-
HUM annual gross profit margin value is unknown

Operating profit

-
HUM annual operating income value is unknown

Operating margin

-
HUM annual operating profit margin value is unknown

Net income

$1.21B
HUM annual net profit is $1.21 billion

Net margin

1.03%
HUM annual net profit margin is 1.03%

Expenses

Total expenses

$116.04B
HUM annual total expenses is $116.04 billion

Operating expenses

$14.72B
HUM annual total operating expenses is $14.72 billion

Cost of goods sold

-
HUM annual cost of goods sold value is unknown

Selling, general & administrative expenses

-
HUM annual SGA value is unknown

Depreciation and amortization

$968.00M
HUM annual depreciation & amortization is $968.00 million

Interest expense

$660.00M
HUM annual interest expense is $660.00 million

Income tax

$413.00M
HUM annual income tax is $413.00 million

EBIT & EBITDA

EBIT

$2.38B
HUM annual earnings before interest & taxes is $2.38 billion

EBITDA

$3.35B
HUM annual EBITDA is $3.35 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$46.48B
HUM annual total assets is $46.48 billion

Non current assets

$41.55B
HUM annual long term assets is $41.55 billion

Current assets

$23.14B
HUM annual total current assets is $23.14 billion

Cash and cash equivalents

$2.22B
HUM annual cash & cash equivalents is $2.22 billion

Accounts receivable

$2.70B
HUM annual accounts receivable is $2.70 billion

Inventory

-
HUM annual inventory value is unknown

Liabilities

Total liabilities

$30.03B
HUM annual total liabilities is $30.03 billion

Long term liabilities

$11.40B
HUM annual total long term liabilities is $11.40 billion

Current liabilities

$16.68B
HUM annual total current liabilities is $16.68 billion

Accounts payable

$15.70B
HUM annual accounts payable is $15.70 billion

Debt

Total debt

$11.72B
HUM annual total debt is $11.72 billion

Total debt 1-year change

+0.56%
HUM annual total debt is up +0.56% year-on-year

Long term debt

$11.14B
HUM annual long term debt is $11.14 billion

Short term debt

$577.00M
HUM annual short term debt is $577.00 million

Equity & Capital

Shareholders equity

$16.38B
HUM annual stockholders equity is $16.38 billion

Book value

$16.38B
HUM annual book value is $16.38 billion

Retained earnings

$28.32B
HUM annual retained earnings is $28.32 billion

Working capital

$6.46B
HUM annual working capital is $6.46 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$2.97B
HUM annual cash flow from operations is $2.97 billion

Cash from operations 1-year change

-25.5%
HUM annual cash flow from operations is down -25.5% year-on-year

Cash from investing

-$2.95B
HUM annual cash flow from investing activities is -$2.95 billion

Cash from investing 1-year change

+15.46%
HUM annual cash flow from investing activities is up +15.46% year-on-year

Cash from financing

-$2.49B
HUM annual cash flow from financing activities is -$2.49 billion

Cash from financing 1-year change

-190.54%
HUM annual cash flow from financing activities is down -190.54% year-on-year

CAPEX

CAPEX

$575.00M
HUM annual capital expenditures is $575.00 million

CAPEX 1-year change

-42.73%
HUM annual capital expenditures is down -42.73% year-on-year

Free Cash Flow

Free cash flow

$2.39B
HUM annual free cash flow is $2.39 billion

Free cash flow 1-year change

-19.68%
HUM annual free cash flow is down -19.68% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
HUM annual gross profit margin value is unknown

Operating margin

-
HUM annual operating profit margin value is unknown

Net margin

1.03%
HUM annual net profit margin is 1.03%

ROA & ROE

ROA

2.58%
HUM annual return on assets is 2.58%

ROE

7.37%
HUM annual return on equity is 7.37%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

28.63
HUM price to earnings ratio is 28.63

PE ratio Sector rank

58.33%
HUM price to earnings ratio is higher than 58.33% of companies in Healthcare sector

PB Ratio

PB ratio

2.10
HUM price to book ratio is 2.10

PB ratio Sector rank

63.46%
HUM price to book ratio is higher than 63.46% of companies in Healthcare sector

PS Ratio

PS ratio

0.29
HUM price to sales ratio is 0.29

PS ratio Sector rank

9.74%
HUM price to sales ratio is higher than 9.74% of companies in Healthcare sector

Enterprise value

Enterprise value

$43.86B
HUM enterprise value is $43.86 billion

Enterprise value Sector rank

97.36%
HUM enterprise value is higher than 97.36% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

13.10
HUM EV/EBITDA is 13.10

EV/EBITDA Sector rank

85.91%
HUM EV/EBITDA is higher than 85.91% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.39
HUM annual current ratio is 1.39

Quick ratio

-
HUM annual quick ratio value is unknown

Leverage

Debt to equity

0.72
HUM annual debt to equity ratio is 0.72

Interest coverage ratio

3.61
HUM annual interest coverage ratio is 3.61

Risk & Stability

Piotroski F-Score

-
HUM piotroski f-score value is unknown

Altman Z-Score

4.41
HUM altman z-score is 4.41

Analyst ratings

Recent major analysts updates

Apr 11, 25 Truist Securities
Hold
Apr 11, 25 Barclays
Equal-Weight
Apr 9, 25 Mizuho
Outperform
Apr 9, 25 Guggenheim
Buy
Feb 18, 25 JP Morgan
Neutral
Feb 13, 25 Barclays
Equal-Weight
Feb 12, 25 RBC Capital
Outperform
Feb 12, 25 Morgan Stanley
Equal-Weight
Feb 12, 25 Cantor Fitzgerald
Neutral
Jan 22, 25 Barclays
Equal-Weight

Institutional Ownership

Similar stocks

IDXX logo
IDEXX Laboratories (IDXX)
CAH logo
Cardinal Health (CAH)
VEEV logo
Veeva Systems (VEEV)
ARGX logo
argenx SE (ARGX)
RMD logo
ResMed (RMD)
CNC logo
Centene (CNC)
ALNY logo
Alnylam Pharmaceuticals (ALNY)
A logo
Agilent Technologies (A)
GEHC logo
GE HealthCare Technologies (GEHC)
  • What is the ticker symbol for Humana?
  • Does Humana pay dividends?
  • What sector is Humana in?
  • What industry is Humana in?
  • What country is Humana based in?
  • When did Humana go public?
  • Is Humana in the S&P 500?
  • Is Humana in the NASDAQ 100?
  • Is Humana in the Dow Jones?
  • When was Humana's last earnings report?
  • When does Humana report earnings?
  • Should I buy Humana stock now?

What is the ticker symbol for Humana?

The ticker symbol for Humana is NYSE:HUM

Does Humana pay dividends?

Yes, Humana pays dividends. The last payment was $0.89, with an ex-dividend date on March 28, 2025

What sector is Humana in?

Humana is in the Healthcare sector

What industry is Humana in?

Humana is in the Healthcare Plans industry

What country is Humana based in?

Humana is headquartered in United States

When did Humana go public?

Humana's initial public offering (IPO) was on December 31, 1981

Is Humana in the S&P 500?

Yes, Humana is included in the S&P 500 index

Is Humana in the NASDAQ 100?

No, Humana is not included in the NASDAQ 100 index

Is Humana in the Dow Jones?

No, Humana is not included in the Dow Jones index

When was Humana's last earnings report?

Humana's most recent earnings report was on Feb 11, 2025

When does Humana report earnings?

The next expected earnings date for Humana is Apr 30, 2025

Should I buy Humana stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page